An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
This study is for people with a severe inherited bleeding condition called Type 3 Von Willebrand Disease. If you're already receiving regular treatment (called 'prophylaxis') for this condition, this study might be for you. Researchers want to learn more about how well these treatments work in real life and how they affect your health and quality of life. They will simply observe your usual care for at least 24 weeks, without changing your treatment. This helps us understand what works best and how to improve care for others with Type 3 Von Willebrand Disease.
Auf einen Blick
Worum geht es in dieser Studie?
This study is for individuals already diagnosed with a serious inherited bleeding disorder called Type 3 Von Willebrand Disease (VWD). This condition means your blood doesn't clot properly, leading to bleeding problems.
The main goal of this study is to gather information on how effective and safe the treatments you currently receive are. You won't be given any new medicines or asked to change your current treatment. Instead, the study will simply observe what you're already doing with your doctor and how your condition affects your daily life over about six months. This approach helps researchers understand the 'real world' impact of current treatments.
By collecting details about your health and how you feel, the study aims to improve our understanding of Type 3 VWD and how best to manage it. This information can help doctors and researchers find better ways to care for people with this condition in the future. It's a way to learn from those who live with VWD every day.
Wichtige Erkenntnisse
- Study for people with Type 3 Von Willebrand Disease already on standard treatment.
- Observes your current care; no new drugs are given.
- Aims to understand treatment effectiveness and quality of life.
- Participating will last at least 24 weeks (6 months).
- Helps improve future care for others with VWD.
- Your medical care will not be affected if you choose not to participate or withdraw.
Wer könnte berechtigt sein?
To join this study, you must have a confirmed diagnosis of severe Type 3 Von Willebrand Disease. You also need to be receiving your usual, regular treatment (called 'prophylactic therapy') for your condition, typically taking it 1 to 3 times a week, and expect to continue this treatment during the study period. Your blood, liver, and kidney functions should be generally healthy.
There are also some important reasons why you might not be able to join. For example, if you have another bleeding disorder, a recent history of stomach or bowel bleeding, or a history of bleeding in the brain, you wouldn't be suitable. People who have had blood clots or are being treated for them, or those with certain other medical conditions affecting bleeding or clotting, would also not be able to participate.
Additionally, if you are pregnant, planning to become pregnant, or are of childbearing age, you would need to agree to use effective contraception throughout the study. If you're taking certain strong immune-system affecting medications (like systemic immunomodulators), you also wouldn't be able to join, though some specific medications like HIV treatments are exceptions.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Do I have a confirmed diagnosis of Type 3 Von Willebrand Disease?
- Am I currently receiving regular (prophylactic) treatment for my VWD?
- Am I generally healthy aside from my VWD, with good liver/kidney function?
- Have I had any recent stomach/bowel bleeds or bleeds in the brain?
- Am I pregnant or planning to become so soon?
- Am I generally able to attend appointments without major issues?
Was beinhaltet die Teilnahme?
If you decide to take part, you will continue with your regular medical appointments and treatments as prescribed by your doctor. The study will mainly involve collecting information from your medical records and asking you about your health and quality of life through questionnaires. This will happen over at least 24 weeks (about 6 months).
You won't receive any new medications or treatments specially for the study. Instead, the researchers will observe your usual care. You'll likely have regular check-ups with the study team to record information, but these are typically planned around your existing appointments. There's no strict number of visits mentioned, as it follows your standard care.
Potenzielle Risiken und Vorteile
Standorte (25)
- UC DavisVerifizierte PostleitzahlSacramento, Vereinigte Staaten
- University of Minnesota Medical CenterVerifizierte PostleitzahlMinneapolis, Vereinigte Staaten
- Washington University School of MedicineVerifizierte PostleitzahlSt. Louis, Vereinigte Staaten
- UZ Leuven GasthuisbergVerifizierte PostleitzahlLeuven, Belgien
- The Hospital for Sick ChildrenVerifizierte PostleitzahlToronto, Kanada
- McGill University Health CenterVerifizierte PostleitzahlMontreal, Kanada
- IPS SURA Industriales MedellínVerifizierte PostleitzahlMedellín, Colombia
- Hopital Claude Huriez - CHU LilleVerifizierte PostleitzahlLille, Frankreich
- Groupe Hospitalier Necker Enfants MaladesVerifizierte PostleitzahlParis, Frankreich
- Universitätsklinikum BonnVerifizierte PostleitzahlBonn, Deutschland
- Gerinnungszentrum Rhein-Ruhr;GerinnungsambulanzVerifizierte PostleitzahlDuisburg, Germany
- Hämophiliezentrum Med. Klinik III/Institut für TransfusionsmedizinUnbestätigtFrankfurt/M., Germany
Häufige Fragen
What is Type 3 Von Willebrand Disease?
It's a serious inherited bleeding disorder where your blood doesn't clot properly, leading to increased bleeding.
Wird sich meine Behandlung ändern, wenn ich an dieser Studie teilnehme?
No, you will continue with your current, regular treatment as usual. The study just observes it.
Wie lange werde ich an der Studie teilnehmen?
You will be observed for at least 24 weeks, which is about 6 months.
Do I need to visit the hospital more often for this study?
The study aims to fit around your existing appointments, so you shouldn't have many extra visits.
What kind of information will they collect?
They will collect details from your medical records and ask you questions about your health and how you feel.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.